Ibaraki, Japan

Hiroshi Nagase

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Nippon Chemiphar Co., Ltd., University of Tsukuba, The Kitasato Institute. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Nagase. Retrieved from https://idiyas.com/inventor/hiroshi-nagase-p3z8xpmi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 69.2

 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Ibaraki, JP (2015 - 2023)
  • Tsukuba, JP (2017 - 2023)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Morphinan Derivative
Opioid Delta Receptor
Therapeutic Treatment
Sulfonamide Derivative
Percutaneous Absorption Patch
Pharmaceutically Acceptable Salt
Medical Usage
Drug Development
Pain Management
Pharmaceutical Chemistry
13 patents (USPTO):Explore Patents

Title: Hiroshi Nagase: Innovator in Pharmaceutical Chemistry

Introduction

Hiroshi Nagase is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 13 patents to his name, he has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents, one focuses on the use of morphinan derivatives for the treatment of opioid delta receptor agonist-related diseases. This method involves administering an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits opioid δ receptor agonist activity. Another notable patent is for a sulfonamide derivative or pharmaceutically acceptable acid-addition salt, which aims to provide a novel low-molecular-weight compound showing orexin receptor agonist activity. This compound is expected to be useful as a prophylactic or therapeutic agent for narcolepsy and similar conditions.

Career Highlights

Hiroshi Nagase has worked with notable organizations such as Nippon Chemiphar Co., Ltd. and the University of Tsukuba. His work in these institutions has allowed him to explore innovative solutions in the field of pharmaceuticals.

Collaborations

Some of his coworkers include Eriko Nakata and Hideaki Fujii, who have collaborated with him on various projects, contributing to the advancement of their shared research goals.

Conclusion

Hiroshi Nagase's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new therapeutic options in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…